920 related articles for article (PubMed ID: 20653478)
1. Efficacy in patients with dry eye after treatment with a new lubricant eye drop formulation.
Davitt WF; Bloomenstein M; Christensen M; Martin AE
J Ocul Pharmacol Ther; 2010 Aug; 26(4):347-53. PubMed ID: 20653478
[TBL] [Abstract][Full Text] [Related]
2. An open-label evaluation of HP-Guar gellable lubricant eye drops for the improvement of dry eye signs and symptoms in a moderate dry eye adult population.
Hartstein I; Khwarg S; Przydryga J
Curr Med Res Opin; 2005 Feb; 21(2):255-60. PubMed ID: 15801996
[TBL] [Abstract][Full Text] [Related]
3. Protecting the ocular surface and improving the quality of life of dry eye patients: a study of the efficacy of an HP-guar containing ocular lubricant in a population of dry eye patients.
Rolando M; Autori S; Badino F; Barabino S
J Ocul Pharmacol Ther; 2009 Jun; 25(3):271-8. PubMed ID: 19366323
[TBL] [Abstract][Full Text] [Related]
4. Lifitegrast ophthalmic solution 5.0% for treatment of dry eye disease: results of the OPUS-1 phase 3 study.
Sheppard JD; Torkildsen GL; Lonsdale JD; D'Ambrosio FA; McLaurin EB; Eiferman RA; Kennedy KS; Semba CP;
Ophthalmology; 2014 Feb; 121(2):475-83. PubMed ID: 24289915
[TBL] [Abstract][Full Text] [Related]
5. Lubricant with gelling agent in treating dry eye in adult Chinese patients.
Waduthantri S; Yong SS; Tan CH; Htoon HM; Tong L
Optom Vis Sci; 2012 Nov; 89(11):1647-53. PubMed ID: 23069726
[TBL] [Abstract][Full Text] [Related]
6. Corneal staining reductions observed after treatment with Systane Lubricant Eye Drops.
Christensen MT
Adv Ther; 2008 Nov; 25(11):1191-9. PubMed ID: 18972076
[TBL] [Abstract][Full Text] [Related]
7. Clinical evaluation of an HP-guar gellable lubricant eye drop for the relief of dryness of the eye.
Christensen MT; Cohen S; Rinehart J; Akers F; Pemberton B; Bloomenstein M; Lesher M; Kaplan D; Meadows D; Meuse P; Hearn C; Stein JM
Curr Eye Res; 2004 Jan; 28(1):55-62. PubMed ID: 14704914
[TBL] [Abstract][Full Text] [Related]
8. Tear osmolarity measurement using the TearLab Osmolarity System in the assessment of dry eye treatment effectiveness.
Benelli U; Nardi M; Posarelli C; Albert TG
Cont Lens Anterior Eye; 2010 Apr; 33(2):61-7. PubMed ID: 20153684
[TBL] [Abstract][Full Text] [Related]
9. Corneal and conjunctival sensitivity in patients with dry eye: the effect of topical cyclosporine therapy.
Toker E; Asfuroğlu E
Cornea; 2010 Feb; 29(2):133-40. PubMed ID: 19966564
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of an enhanced viscosity artificial tear for moderate to severe dry eye disease: A multicenter, double-masked, randomized 30-day study.
Lievens C; Berdy G; Douglass D; Montaquila S; Lin H; Simmons P; Carlisle-Wilcox C; Vehige J; Haque S
Cont Lens Anterior Eye; 2019 Aug; 42(4):443-449. PubMed ID: 30573298
[TBL] [Abstract][Full Text] [Related]
11. A comparison of cyclosporine 0.05% ophthalmic emulsion versus vehicle in Chinese patients with moderate to severe dry eye disease: an eight-week, multicenter, randomized, double-blind, parallel-group trial.
Chen M; Gong L; Sun X; Xie H; Zhang Y; Zou L; Qu J; Li Y; He J
J Ocul Pharmacol Ther; 2010 Aug; 26(4):361-6. PubMed ID: 20698799
[TBL] [Abstract][Full Text] [Related]
12. An evaluation of tear film breakup time extension and ocular protection index scores among three marketed lubricant eye drops.
Ousler GW; Michaelson C; Christensen MT
Cornea; 2007 Sep; 26(8):949-52. PubMed ID: 17721294
[TBL] [Abstract][Full Text] [Related]
13. A randomized, multicenter phase 3 study comparing 2% rebamipide (OPC-12759) with 0.1% sodium hyaluronate in the treatment of dry eye.
Kinoshita S; Oshiden K; Awamura S; Suzuki H; Nakamichi N; Yokoi N;
Ophthalmology; 2013 Jun; 120(6):1158-65. PubMed ID: 23490326
[TBL] [Abstract][Full Text] [Related]
14. A phase 2 randomized, double-masked, placebo-controlled study of a novel integrin antagonist (SAR 1118) for the treatment of dry eye.
Semba CP; Torkildsen GL; Lonsdale JD; McLaurin EB; Geffin JA; Mundorf TK; Kennedy KS; Ousler GW
Am J Ophthalmol; 2012 Jun; 153(6):1050-60.e1. PubMed ID: 22330307
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the Efficacy of Carboxymethylcellulose 0.5%, Hydroxypropyl-guar Containing Polyethylene Glycol 400/Propylene Glycol, and Hydroxypropyl Methyl Cellulose 0.3% Tear Substitutes in Improving Ocular Surface Disease Index in Cases of Dry Eye.
Maharana PK; Raghuwanshi S; Chauhan AK; Rai VG; Pattebahadur R
Middle East Afr J Ophthalmol; 2017; 24(4):202-206. PubMed ID: 29422755
[TBL] [Abstract][Full Text] [Related]
16. A clinical evaluation of Systane.
Gifford P; Evans BJ; Morris J
Cont Lens Anterior Eye; 2006 Mar; 29(1):31-40. PubMed ID: 16473547
[TBL] [Abstract][Full Text] [Related]
17. Lifitegrast Ophthalmic Solution 5.0% versus Placebo for Treatment of Dry Eye Disease: Results of the Randomized Phase III OPUS-2 Study.
Tauber J; Karpecki P; Latkany R; Luchs J; Martel J; Sall K; Raychaudhuri A; Smith V; Semba CP;
Ophthalmology; 2015 Dec; 122(12):2423-31. PubMed ID: 26365210
[TBL] [Abstract][Full Text] [Related]
18. The relief of dry eye signs and symptoms using a combination of lubricants, lid hygiene and ocular nutraceuticals.
Ngo W; Srinivasan S; Houtman D; Jones L
J Optom; 2017; 10(1):26-33. PubMed ID: 27425263
[TBL] [Abstract][Full Text] [Related]
19. Randomized, Multicenter, Double-Blind Study of the Safety and Efficacy of 1%D-3-Hydroxybutyrate eye drops for Dry Eye Disease.
Kawakita T; Uchino M; Fukagawa K; Yoshino K; Shimazaki S; Toda I; Tanaka M; Arai H; Sakatani K; Hata S; Okano T; Tsubota K
Sci Rep; 2016 Feb; 6():20855. PubMed ID: 26865350
[TBL] [Abstract][Full Text] [Related]
20. Rebamipide (OPC-12759) in the treatment of dry eye: a randomized, double-masked, multicenter, placebo-controlled phase II study.
Kinoshita S; Awamura S; Oshiden K; Nakamichi N; Suzuki H; Yokoi N;
Ophthalmology; 2012 Dec; 119(12):2471-8. PubMed ID: 23009892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
